Insulet | صافي الدخل



Net Income تغيير تاريخ
Abbott USD 1.33B 7.9B 2025-03
Align Technology USD 93.23M 10.58M 2025-03
AtriCure USD -6747000 8.82M 2025-03
Avanos Medical USD -397300000 401.6M 2024-12
Baxter International USD -512000000 652M 2024-12
Becton, Dickinson and Co. USD 303M 97M 2024-12
Boston Scientific USD 674M 108M 2025-03
Cardinal Health USD 400M 16M 2024-12
Cooper Companies USD 104.3M 13.2M 2025-01
Dexcom USD 151.7M 17.1M 2024-12
Edwards Lifesciences USD 358M 27.6M 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Globus Medical USD 26.5M 25.33M 2024-12
ICU Medical USD -23828000 9.15M 2024-12
Insulet USD 100.7M 23.2M 2024-12
Integra LifeSciences USD 19.43M 30.13M 2024-12
J&J USD 11B 7.57B 2025-03
Masimo USD -349600000 359.4M 2024-12
Medtronic USD 1.29B 25M 2025-01
Merit Medical Systems USD 30.15M 2.2M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Solventum Corp 31M 91M 2024-12
Stryker USD 546M 288M 2024-12
Tandem Diabetes Care USD -130556000 131.31M 2025-03
Teleflex USD 95M 231.66M 2025-03
West Pharmaceutical Services USD 89.8M 40.3M 2025-03
Zimmer Biomet Holdings USD 239.4M 9.6M 2024-12



Insulet صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.